These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7775940)

  • 1. Prognostic value of adenosine deaminase compared to other markers for progression to acquired immunodeficiency syndrome among intravenous drug users.
    Casoli C; Lisa A; Magnani G; Starcich R; Fiaccadori F; Bertazzoni U; Zei G
    J Med Virol; 1995 Feb; 45(2):203-10. PubMed ID: 7775940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
    Iñigo MA; Ruiz López de Tejada M; Torres-Tortosa M; Sánchez-Porto A; Ugarte I; García de Lomas E; Morán Nestares A
    Med Clin (Barc); 1992 Dec; 99(20):766-8. PubMed ID: 1361013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
    Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
    Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
    Chironna M; Fanelli M; Potenza D; Serio G; Quarto M
    Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users.
    Zabay JM; Sempere JM; Benito JM; Gonzalez B; Obregón E; Díez J; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):266-72. PubMed ID: 7859138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenosine deaminase (ADA) and beta 2-microglobulin (beta 2M) as discriminating serum markers of progression to AIDS].
    Pérez de Oteyza C; Menéndez Martínez MA; Irazábal C; Enríquez de Salamanca R; Pérez Aznar C; Rebollar JL
    An Med Interna; 1996 May; 13(5):217-21. PubMed ID: 8767867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.
    Fernández-Cruz E; Desco M; Garcia Montes M; Longo N; Gonzalez B; Zabay JM
    AIDS; 1990 Oct; 4(10):987-94. PubMed ID: 1979743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of adenosine deaminase determinations in subjects with the lymphoadenopathy syndrome.
    Casoli C; Magnani G; Scovassi I; Bertazzoni U; Starcich R
    J Med Virol; 1988 Apr; 24(4):413-22. PubMed ID: 3163359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA as a marker of clinical progression among HIV-seropositive intravenous drug users.
    Gafà S; Giudici MG; Pezzotti P; Rezza G
    J Infect; 1993 Jan; 26(1):33-8. PubMed ID: 8095958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adenosine deaminase levels in intravenous drug users with and without infection due to human immunodeficiency virus.
    Iñigo MA; López de Tejada MR; Torres-Tortosa M; Sánchez-Porto A
    Clin Infect Dis; 1994 Mar; 18(3):478-9. PubMed ID: 8011844
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
    Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
    AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers for disease progression in intravenous drug users infected with HIV-1.
    Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H
    AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
    Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study.
    Saah AJ; Muñoz A; Kuo V; Fox R; Kaslow RA; Phair JP; Rinaldo CR; Detels R; Polk BF
    Am J Epidemiol; 1992 May; 135(10):1147-55. PubMed ID: 1352940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
    Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.
    Visconti A; Visconti L; Bellocco R; Binkin N; Colucci G; Vernocchi L; Amendola M; Ciaci D
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1228-37. PubMed ID: 7901382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators for development of AIDS among intravenous drug users.
    Muñoz A; Vlahov D; Solomon L; Margolick JB; Bareta JC; Cohn S; Astemborski J; Nelson KE
    J Acquir Immune Defic Syndr (1988); 1992; 5(7):694-700. PubMed ID: 1613668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.